Global advisory committee on research, impact and strategy

The Advisory Committee on Research, Impact and Strategy (ACRIS) is an independent body which meets every five years. ACRIS provides advice on future research directions to the Institute’s Board of Directors and senior management. Its membership comprises highly respected individuals who have influenced health and medical research, or have shaped health policy and practice globally.

The last meeting of the committee was held in February 2018. Within the scope of the Institute’s mission, as well as the Institute’s ambition to have a major impact on health policy and practice worldwide, ACRIS members helped:

  • guide and assist the Institute in identifying key health challenges globally over the next five to 20 years;
  • review the Institute’s current and planned areas of focus and its activities in terms of impact, or potential for impact, on the identified key health challenges; and
  • made recommendations regarding the best strategies for the Institute to pursue to maximise its future impact on these challenges.

  • Garry Jennings AO

    • Executive Director at Sydney Health Partners

    Professor Jennings is Executive Director of Sydney Health Partners. He was the Director and Chief Executive Officer of Baker IDI Heart and Diabetes Institute. From January 2016 he was interim Chief Executive Officer and Chief Medical Adviser of the National Heart Foundation of Australia.

  • Mr Martin Bowles PSM

    • NCEO, Calvary Health Care

    Martin Bowles is the National Chief Executive Office of Calvary Health Care, taking up his appointment in November of 2017. He was previously Secretary of the Australian Commonwealth Department of Health since October 2014. He led reforms in primary health care and mental health service arrangements, access to medical and pharmaceutical benefits, aged care, hospital funding and digital health.  

  • Katie Dain

    • Chief Executive Officer (London), NCD Alliance

    Ms Dain has worked with the NCD Alliance since its founding in 2009. Her experience has included organisational and strategic development, global advocacy and policy-making, and program design and capacity-building in low- and middle-income countries.

  • Shahid Jameel

    • Chief Executive Officer at The Wellcome Trust / DBT India Alliance

    Dr Shahid Jameel has been Chief Executive Officer of the Wellcome Trust/DBT India Alliance since April 2013. He did his PhD in Biochemistry from Washington State University (USA) and his postdoctoral work in Molecular Virology from the University of Colorado Medical School (USA).

  • Anne Mills

    United Kingdom

    • London School of Hygiene & Tropical Medicine

    Professor Anne Mills is Deputy Director and Provost of the London School of Hygiene & Tropical Medicine, and Professor of Health Economics and Policy. She has degrees from Oxford University (MA), Leeds University (Diploma), and London University (PhD).

  • Karen Sliwa-Hahnle

    • Director, The Hatter Institute for Cardiovascular Research in Africa

    Professor Karen Sliwa-Hahnle is the Director of the Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, South Africa. Born in Germany, she studied medicine, undergoing training as a physician and cardiologist in a number of countries. Professor Sliwa-Hahnle has lived in South Africa since 1992.

  • Professor Tan Chorh Chuan

    • President of the National University of Singapore

    Professor Tan Chorh Chuan was appointed as the inaugural Chief Health Scientist and concurrently, Executive Director of the new Office for Healthcare Transformation in Singapore’s Ministry of Health with effect from 1 January 2018. Professor Tan’s concurrent appointments include the Chairman of the Board of the National University Health System; member, Board of Directors of the Monetary Authority of Singapore; and member, Board of Directors of Mandai Park Development. Professor Tan served as President of the National University of Singapore (NUS) from 2008 to 2017.